Loading…
Shuttle Pharmaceuticals Holdings, Inc. is projected to rise to $3.83 by 2027, a +14% move from its current price of $3.37. SHPH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.11 | $3.37 | $3.66 | +0.09% |
| Aug 6 | $3.01 | $3.38 | $3.79 | +0.18% |
| Aug 7 | $2.93 | $3.38 | $3.90 | +0.28% |
| Aug 8 | $2.87 | $3.38 | $3.99 | +0.37% |
| Aug 9 | $2.82 | $3.39 | $4.07 | +0.46% |
| Aug 10 | $2.77 | $3.39 | $4.14 | +0.56% |
| Aug 11 | $2.73 | $3.39 | $4.21 | +0.65% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.73 | $3.39 | $4.21 | +0.65% |
| Week 2 | $2.51 | $3.41 | $4.64 | +1.30% |
| Week 3 | $2.36 | $3.44 | $5.01 | +1.96% |
| Week 4 | $2.24 | $3.46 | $5.34 | +2.62% |
| Week 5 | $2.14 | $3.48 | $5.66 | +3.29% |
| Week 6 | $2.06 | $3.50 | $5.96 | +3.96% |
| Week 7 | $1.98 | $3.53 | $6.26 | +4.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company that develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Shuttle Pharmaceuticals Holdings, Inc. trades under the symbol SHPH and has a current price of $3.80. The company carries a market cap of $2.22M and is ranked 5431 by market capitalization.
A major floor 86.5% below — a decisive break under it would weaken the trend.
The nearest floor, 17.5% below — buyers have tended to step in here.
The nearest ceiling, 23.4% above — a clean break opens room to run.
A major ceiling 47.2% above — clearing it would confirm fresh momentum.
Key SHPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SHPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.08 | Buy | $3.24 | Buy |
| MA 10 | $3.07 | Buy | $3.17 | Buy |
| MA 20 | $3.24 | Buy | $3.17 | Buy |
| MA 50 | $2.74 | Buy | $2.78 | Buy |
| MA 100 | $1.79 | Buy | $2.34 | Buy |
| MA 200 | $1.87 | Buy | $3.96 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.50 | Neutral |
| Stoch RSI (14) | 82.23 | Sell |
| CCI (20) | 125.42 | Buy |
| Williams %R (14) | -26.09 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | 4.11 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 73.91 | Neutral |
| TRIX (15) | 0.34 | Buy |
| Awesome (5,34) | -0.35 | Sell |
| Ultimate (7,14,28) | 68.61 | Neutral |
| Momentum (10) | 0.64 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 3.15 | Buy |
| ADX (14) | 13.06 | Neutral |
| ATR (14) | 0.28 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 50. The moving averages show SMA50 at $4.00 and SMA200 at $12.80. Support is at $2.78 and resistance at $4.16, while the 30-day price range spans from $2.21 to $6.53.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.78 | $3.37 | $4.45 | 0% | Neutral | |
| $2.79 | $3.83 | $5.67 | +14% | Neutral | |
| $3.59 | $5.24 | $8.29 | +55% | Bullish | |
| $3.41 | $5.24 | $8.71 | +56% | Bullish | |
| $3.51 | $5.66 | $9.79 | +68% | Bullish | |
| $2.91 | $4.90 | $8.78 | +45% | Bullish | |
| $2.26 | $3.98 | $7.35 | +18% | Neutral | |
| $2.72 | $4.98 | $9.46 | +48% | Bullish | |
| $2.65 | $5.04 | $9.83 | +50% | Bullish | |
| $3.04 | $6.02 | $12.01 | +79% | Bullish | |
| $2.46 | $5.47 | $12.00 | +62% | Bullish | |
| $6.36 | $14.13 | $32.49 | +319% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.78 | $3.37 | $3.93 | +0.00% |
| September 2026 | $2.77 | $3.37 | $4.27 | -0.02% |
| October 2026 | $2.97 | $3.67 | $4.74 | +8.81% |
| November 2026 | $2.81 | $3.50 | $4.61 | -4.44% |
| December 2026 | $2.65 | $3.33 | $4.45 | -4.89% |
Click any year to see its month-by-month SHPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SHPH could reach as high as $4.45, with a base case around $3.37 and support toward $2.78 — roughly 0% from $3.37. Price action looks broadly range-bound.
Expect SHPH to range from $2.79 to $5.67 through 2027. The $3.83 average target implies a +14% move from current prices. That is up +14% on the projected 2026 average. A consolidation phase looks the most probable path here.
The SHPH price prediction for 2028 points to an average of $5.24 (low $3.59, high $8.29) — a potential gain of +55% on today's $3.37. Momentum favours further upside here.
In 2029, SHPH is projected to trade between $3.41 and $8.71, averaging $5.24 — a potential gain of +56% from today's $3.37. That is up 0% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Shuttle Pharmaceuticals Holdings, Inc.'s 2030 outlook centres on $5.66, within a $3.51 to $9.79 range. That is up +8% on the projected 2029 average. That marks a +68% change versus current levels. Momentum favours further upside here.
By 2031, SHPH could reach as high as $8.78, with a base case around $4.90 and support toward $2.91 — roughly +45% from $3.37. Buyers look set to stay in control over this stretch.
Expect SHPH to range from $2.26 to $7.35 through 2032. The $3.98 average target implies a +18% move from current prices. That is -19% versus the projected 2031 average. Price action looks broadly range-bound.
The SHPH price prediction for 2033 points to an average of $4.98 (low $2.72, high $9.46) — a potential gain of +48% on today's $3.37. Buyers look set to stay in control over this stretch.
In 2034, SHPH is projected to trade between $2.65 and $9.83, averaging $5.04 — a potential gain of +50% from today's $3.37. That is up +1% on the projected 2033 average. Momentum favours further upside here.
Shuttle Pharmaceuticals Holdings, Inc.'s 2035 outlook centres on $6.02, within a $3.04 to $12.01 range. That is up +19% on the projected 2034 average. That marks a +79% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, SHPH could reach as high as $12.00, with a base case around $5.47 and support toward $2.46 — roughly +62% from $3.37. Momentum favours further upside here.
Expect SHPH to range from $6.36 to $32.49 through 2050. The $14.13 average target implies a +319% move from current prices. That is up +158% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in SHPH today (≈ 296.735905 SHPH) could be worth
$4,191.47
+$3,191.47 (+319%) by 2050 · US Dollar
Based on the average projected SHPH price of $14.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SHPHwould be worth at today's price.
$1,000 invested in SHPH on Jul 31, 2025 (≈ 273.972596 SHPH) would be worth
$923.29
-$76.71 (-7.7%) today · 0.92× · US Dollar
Based on a SHPH entry price of $3.65 vs. today's $3.37.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.89 | $1,166.09 | +16.6% |
| 1 month ago | $3.4 | $991.18 | -0.9% |
| 3 months ago | $0.692 | $4,869.94 | +387.0% |
| 6 months ago | $1.79 | $1,882.68 | +88.3% |
| 1 year ago | $3.65 | $923.29 | -7.7% |
| All time (3.9y) ago | $7,696 | $0.44 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SHPH forecast.
Our base-case forecast reaches $6.70 around 2050.
Implied market cap at $6.70: $3.92M
The multi-year forecast indicates a bullish tilt across the horizon, with the 2026 average price at $3.80 and the 2050 average at $15.92. Notable mid-term values include 2028 average $5.89 (55.1% ROI) and 2029 average $5.91 (55.6% ROI), while 2030 average is $6.37 (67.6% ROI) and 2040 average is $6.15 (61.9% ROI). By 2050, the forecast shows an average of $15.92 with a maximum of $36.62 and a 318.9% ROI.
Throughout the horizon, sentiment is bullish in many years, with occasional neutral years such as 2026 and 2032. These projections are estimates and depend on many factors; actual results may differ.
Tap a question to reveal the answer.
Avg price $6.37, min $3.95, max $11.03, ROI 67.6%, sentiment BULLISH.
Forecasts show a bullish trajectory in several years, with 2028 avg $5.89 (ROI 55.1%), 2029 avg $5.91 (ROI 55.6%), 2030 avg $6.37 (ROI 67.6%), and 2050 avg $15.92 (ROI 318.9%); note 2026 currently indicates ROI 0 and neutral sentiment.
The forecast maximums show 2030 max $11.03, 2034 max $11.05, 2035 max $13.53, and 2050 max $36.62, so $50 is above the projected max.
Min $2.78, Avg $3.80, Max $5.02, ROI 0%, sentiment NEUTRAL.
Current price $3.80; market cap $2.22M; rank 5431.
Shuttle Pharmaceuticals Holdings, Inc. Community Discussion
0Share your Shuttle Pharmaceuticals Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.